NASH Commented Articles 2024 - Page 13 Of 42

NASH Observatory Commented Articles

Identify the risk of NASH and cirrhosis: the time to screen is now

Authors: Cusi K.

Published in J Clin Endocrinol Metab 2022

Early screening and risk stratification for advanced liver fibrosis is critical in primary care and endocrinology clinics to prevent future cirrhosis in groups.....

ByDr. G. Bozet, MD
OnAugust 24, 2022

NASH Observatory Commented Articles

NAFLD and structural heart, systolic and diastolic dysfunction: a meta-analysis

Authors: Yong JN, Ng CH, Lee CW, et al.

Published in Hepatol Int 2022

Several studies have documented a relationship between non-alcoholic fatty liver disease (NAFLD) and structural heart disease, particularly diastolic function. This meta-analysis by J. N. Yong et al. (Yong Loo.....

ByDr. D. Beard
OnAugust 24, 2022

NASH Observatory Commented Articles

Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study

Authors: Li Q, Wang L, Wu J, et al.

Published in BMJ Open 2022

In this cross-sectional population-based study, the authors aimed to explore the association between visceral adiposity index and NAFLD in the general US.....

ByDr. G. Bozet, MD
OnAugust 22, 2022

NASH Observatory Commented Articles

Advanced liver fibrosis in NAFLD and antiplatelet therapy: a meta-analysis

Authors: Thongtan T, Deb A, Vutthikraivit W, et al.

Published in Indian J Gastroenterol 2022

Recent studies have found the new use of antiplatelet agents for antifibrotic benefits in NAFLD, but human studies are still limited. The authors of this meta-analysis aimed to combine the findings.....

ByDr. D. Beard
OnAugust 22, 2022

NASH Observatory Commented Articles

Histopathological Diagnosis of NASH

Authors: Wang W, Ma Y, He T, et al.

Published in Methods Mol Biol 2022

Fatty acid beta oxidation is a predominant bioenergetic pathway in mammals. Substantial investigations have demonstrated that fatty acid.....

ByDr. G. Bozet, MD
OnAugust 18, 2022

NASH Observatory Commented Articles

NASH-related fibrosis: MEFIB has higher diagnostic accuracy than FAST

Authors: Tamaki N, Imajo K, Sharpton S, et al.

Published in Hepatology 2022

In this study, the authors compared the diagnostic accuracy of MEFIB (the combination of magnetic resonance elastography and Fibrosis-4) and FAST for detecting.....

ByDr. D. Beard
OnAugust 18, 2022

NASH Observatory Commented Articles

H. pylori infection and NAFLD in China

Authors: Wang W, Fan M, Gong R, et al.

Published in BMC Gastroenterol 2022

The role of H. pylori infection in the development of NAFLD remains controversial. This retrospective study was conducted on 71,633 participants. .....

ByDr. D. Beard
OnAugust 16, 2022

NASH Observatory Commented Articles

Accuracy of serum biomarkers versus liver biopsy

Authors: Mikolasevic I, Domislovic V, Krznaric-Zrnic I, et al.

Published in Medicina (Kaunas) 2022

This first study on Croatian patients with NAFLD was conducted to evaluate the diagnostic performance of various biomarkers for steatosis, fibrosis, and inflammation in comparison to a liver biopsy.....

ByDr. G. Bozet, MD
OnAugust 16, 2022

NASH Observatory Commented Articles

Attenuation coefficient liver to spleen ratio and determination of hepatic steatosis

Authors: Gao J.

Published in Clin Imaging 2022

The aim of the study was to assess ultrasound attenuation coefficient in adult liver and spleen. The authors calculated attenuation coefficient liver to spleen ratio.....

ByDr. G. Bozet, MD
OnAugust 12, 2022

NASH Observatory Commented Articles

Bile acids profile and transition from NAFLD into NASH

Authors: Nimer N, Choucair I, Wang Z, et al.

Published in Metabolism 2021

Metabolomic studies suggest plasma levels of bile acids are elevated amongst subjects with NAFLD compared to healthy controls. However, it remains unclear.....

ByDr. D. Beard
OnAugust 12, 2022

NASH Observatory Commented Articles

Investigating hepatocellular inflammasome activation

Authors: Das D, Adak M, Chakrabarti P.

Published in Methods Mol Biol 2022

Inflammasome activation followed by maturation has been observed in both preclinical models and NASH patients suggesting the crucial importance of inflammasome activation in NAFLD progression......

ByDr. G. Bozet, MD
OnAugust 10, 2022

NASH Observatory Commented Articles

Pathophysiological roles of cell death in NASH

Authors: Tsurusaki S, Kanegae K, Tanaka M.

Published in Methods Mol Biol 2022

The conventional detection of necrosis in vivo is not currently available, whereas the detection method for apoptosis has been relatively well-established ....

ByDr. D. Beard
OnAugust 10, 2022

SLIDES

Commented articles

Video Library

Commented Articles

Identify the risk of NASH and cirrhosis: the time to screen is now

NAFLD and structural heart, systolic and diastolic dysfunction: a meta-analysis

Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study

Advanced liver fibrosis in NAFLD and antiplatelet therapy: a meta-analysis

Histopathological Diagnosis of NASH

NASH-related fibrosis: MEFIB has higher diagnostic accuracy than FAST

H. pylori infection and NAFLD in China

Accuracy of serum biomarkers versus liver biopsy

Attenuation coefficient liver to spleen ratio and determination of hepatic steatosis

Bile acids profile and transition from NAFLD into NASH

Investigating hepatocellular inflammasome activation

Pathophysiological roles of cell death in NASH

Hepatic inflammatory responses in liver fibrosis

Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice

Surveying Stigma: MAFLD’s Nomenclature from Patient and Provider Perspectives

Cardiovascular Disease in MASLD Patients: Mitigating Risks

Delving into the Latest Advancements in MASLD Treatment: Key Insights from Prof. Wong’s presentations at AASLD

Exploring the Promise of Pan-PPAR Agonism

Advancing Fibrosis Imaging: An Evaluation of Radiotracer Efficacy

Geographical burden of NAFLD: a review

SUBSCRIBE & FOLLOW US

SUBSCRIBE TO OUR MONTHLY NEWSLETTER TO GET THE LATEST UPDATES